Glucosamine Sulphate and Increased Level of Blood Cholesterol

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00251069
Recruitment Status : Completed
First Posted : November 9, 2005
Last Update Posted : November 9, 2005
Pharma Nord
Information provided by:

Brief Summary:
Glucosamine sulphate causes no changes in blood levels of cholesterol

Condition or disease Intervention/treatment Phase
Osteoarthritis Drug: Glucosamine sulphate Phase 4

Detailed Description:
The effects on glucosamine sulphate on blood levels of choleterol is measuered in patients with mild to moderate osteoarthritis

Study Type : Interventional  (Clinical Trial)
Enrollment : 66 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Glucosamine Sulphate and Hypercholesterolaemia
Study Start Date : April 2005
Study Completion Date : August 2005

Primary Outcome Measures :
  1. Levels of blood cholesterol

Secondary Outcome Measures :
  1. Effect of treatment on pain

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   40 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria: Osteoarthritic pain, normal blood cholesterol levels -

Exclusion Criteria: Systemic diseases, pregnancy, need of medication besides painkillers

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00251069

Ishøj, Denmark, DK-2635
Sponsors and Collaborators
Pharma Nord
Principal Investigator: Keld Ostergaard, M.D., Ph.D. Slidgigtinstituttet Identifier: NCT00251069     History of Changes
Other Study ID Numbers: EudraCTnr 2005-000541-11
First Posted: November 9, 2005    Key Record Dates
Last Update Posted: November 9, 2005
Last Verified: July 2005

Keywords provided by Slidgigtinstituttet:
glucosamine sulphate, osteoarthritis, cholesterol,

Additional relevant MeSH terms:
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases